RekrutujeFaza III
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic…
Miasta: Brzozów, Katowice, Kraków, Lublin i 1 inne miastoWiek: od 18 latSponsor: BeOne Medicines I GmbH
RekrutujeFaza IV
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Miasta: Brzozów, Bydgoszcz, KatowiceWiek: od 18 latSponsor: Eli Lilly and Company
RekrutujeFaza III
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both…
Miasta: Brzozów, Katowice, Kraków, Lublin i 2 inne miastaWiek: od 18 latSponsor: BeOne Medicines AG
RekrutujeFaza III
MAGIC AML - Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy - of Acute Myeloid Leukemia
Miasta: Białystok, Brzozów, Bydgoszcz, Chorzów i 12 innych miastWiek: od 18 latSponsor: Medical University Of Lodz
RekrutujeFaza II
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
Miasta: Biała Podlaska, Brzozów, Gdynia, Kielce i 3 inne miastaWiek: od 18 latSponsor: Janssen - Cilag International